Showing 8961-8970 of 20877 results for "".
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
https://reachmd.com/programs/medical-industry-feature/anti-amyloid-therapy-early-alzheimers-real-world/48941/Explore the clinical use of the anti-amyloid therapy LEQEMBI® (lecanemab-irmb) for early Alzheimer’s disease in this four-part, on-demand video series. The program offers expert-led guidance on patient selection and monitoring, 4-year efficacy and safety data, and emerging real-world evidence. FeatuNavigating Neuropsychiatric Lupus: Improving Diagnosis and Treatment
https://reachmd.com/programs/living-rheum/navigating-neuropsychiatric-lupus-improving-diagnosis-and-treatment/28633/Hear about advancements in neuropsychiatric lupus management, including improved symptom characterization and emerging treatment options.Advances in IgAN: New Frontiers in Biomarkers and Treatment
https://reachmd.com/programs/frontlines-iga-nephropathy/advances-in-igan-new-frontiers-in-biomarkers-and-treatment/26944/How can understanding the pathogenesis of IgA nephropathy lead to targeted therapies that slow disease progression? Tune in to find out.COVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
https://reachmd.com/programs/clinicians-roundtable/covid-19-in-pregnant-and-pediatric-populations-vaccine-access-and-advocacy/36415/Even after the emergency phase of the pandemic, COVID-19 continues to pose risks for pregnant women, postpartum individuals, and young children, which is why enhancing representation in research and access to care is so pivotal. Join Dr. Flor Muñoz to hear about strategies for improving vaccine confClinical Features and Outcomes of IOFB Removal
https://reachmd.com/programs/new-retina-radio/clinical-features-and-outcomes-of-iofb-removal/48974/What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and REvaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
https://reachmd.com/programs/project-oncology/azacitidine-venetoclax-aml-phase-2-paradigm-trial/39973/At the 2025 American Society of Hematology Annual Meeting, researchers presented pivotal findings from the phase 2 PARADIGM trial on azacitidine and venetoclax in patients with acute myeloid leukemia (AML). In this AudioAbstract, Ryan Quigley shares key findings on how this lower-intensity regimen cDiscussing the Complications of IBS Mimickers
https://reachmd.com/programs/gi-insights/discussing-the-complications-of-ibs-mimickers/24057/What are IBS mimickers? Tune in.IBD and Pregnancy: Key Considerations for Patient Management
https://reachmd.com/programs/gi-insights/ibd-and-pregnancy-key-considerations-for-patient-management/32324/Learn about inflammatory bowel disease, its impact on pregnancy, and best practices for monitoring and treating pregnant patients.The Hidden Costs of IV-Push Controlled Substance Waste in Hospitals
https://reachmd.com/programs/clinicians-roundtable/iv-push-controlled-substance-waste-costs/60597/IV-push controlled substance waste creates far-reaching challenges that extend well beyond medication disposal. In fact, a recent multicenter study evaluated more than 4,400 controlled substance transactions across 16 hospitals and found significant documentation variability, frequent partial-dose wBreakthrough Technology Improves Concussion Assessment and Player Safety
https://reachmd.com/programs/medical-industry-feature/breakthrough-technology-improves-concussion-assessment-and-player-safety/29926/Learn about a new eye-tracking tool that can detect a biomarker indicative of concussion, bringing clinicians closer to objective diagnosis and more informed decision-making.